ATHA Insider Trading

Insider Ownership Percentage: 14.90%
Insider Buying (Last 12 Months): $397,383.84
Insider Selling (Last 12 Months): $0.00

Athira Pharma Insider Trading History Chart

This chart shows the insider buying and selling history at Athira Pharma by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Athira Pharma Share Price & Price History

Current Price: $1.97
Price Change: Price Increase of +0.1 (5.35%)
As of 12/8/2023 01:00 AM ET

This chart shows the closing price history over time for ATHA up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Athira Pharma Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
6/7/2023Andrew GengosInsiderBuy15,000$3.43$51,450.0080,012View SEC Filing Icon  
6/5/2023Andrew GengosInsiderBuy45,000$3.00$135,000.0065,012View SEC Filing Icon  
6/2/2023Andrew GengosInsiderBuy20,012$2.82$56,433.8420,012View SEC Filing Icon  
3/29/2023James A JohnsonDirectorBuy5,000$2.40$12,000.005,000View SEC Filing Icon  
12/28/2022Glenna MilesonCFOBuy50,000$2.85$142,500.00159,930View SEC Filing Icon  
12/2/2022Kelly A RomanoDirectorBuy30,000$3.29$98,700.0038,315View SEC Filing Icon  
11/15/2022Hans MoebiusInsiderBuy5,000$3.29$16,450.0065,836View SEC Filing Icon  
6/29/2022Perceptive Advisors LlcDirectorBuy270,000$2.99$807,300.003,695,916View SEC Filing Icon  
6/28/2022Hans MoebiusInsiderBuy10,000$2.88$28,800.0052,955View SEC Filing Icon  
6/23/2022Mark James LittonCEOSell7,960$2.69$21,412.40128,555View SEC Filing Icon  
6/23/2022Mark WorthingtonGeneral CounselSell2,614$2.69$7,031.6619,097View SEC Filing Icon  
6/23/2022Rachel LeningtonCOOSell4,193$2.69$11,279.175,807View SEC Filing Icon  
3/31/2022Kelly A RomanoDirectorBuy8,000$13.11$104,880.00View SEC Filing Icon  
1/25/2021Perceptive Advisors LlcDirectorBuy311,111$22.50$6,999,997.50View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Athira Pharma (NASDAQ:ATHA)

62.74% of Athira Pharma stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ATHA by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Athira Pharma Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/30/2023American Century Companies Inc.15,269$31K0.0%N/A0.040%Search for SEC Filing on Google Icon
11/17/2023Jacobs Levy Equity Management Inc.299,661$0.61M0.0%+49.3%0.787%Search for SEC Filing on Google Icon
11/15/2023GSA Capital Partners LLP297,052$0.60M0.1%-14.3%0.780%Search for SEC Filing on Google Icon
11/15/2023Laird Norton Trust Company LLC178,709$0.36M0.0%+21.3%0.470%Search for SEC Filing on Google Icon
11/14/2023Nan Fung Group Holdings Ltd180,000$0.36M0.3%+1,429.4%0.473%Search for SEC Filing on Google Icon
11/13/2023Acadian Asset Management LLC139,542$0.28M0.0%-43.0%0.367%Search for SEC Filing on Google Icon
11/9/2023UBS Group AG99,502$0.20M0.0%+251.6%0.261%Search for SEC Filing on Google Icon
11/7/2023Barclays PLC435,841$0.88M0.0%+99.1%1.145%Search for SEC Filing on Google Icon
10/27/2023Marquette Asset Management LLC30,783$62K0.0%N/A0.081%Search for SEC Filing on Google Icon
10/27/2023Acuitas Investments LLC149,600$0.30M0.2%N/A0.393%Search for SEC Filing on Google Icon
10/23/2023BML Capital Management LLC1,704,362$3.44M3.2%-8.6%4.478%Search for SEC Filing on Google Icon
10/19/2023Clarius Group LLC39,427$80K0.0%N/A0.104%Search for SEC Filing on Google Icon
8/21/2023Osaic Holdings Inc.146,969$0.43M0.0%+7.1%0.386%Search for SEC Filing on Google Icon
8/15/2023Wells Fargo & Company MN12,834$38K0.0%-31.1%0.034%Search for SEC Filing on Google Icon
8/15/2023Y Intercept Hong Kong Ltd37,289$0.11M0.0%N/A0.098%Search for SEC Filing on Google Icon
8/15/2023Goldman Sachs Group Inc.17,416$51K0.0%-86.6%0.046%Search for SEC Filing on Google Icon
8/15/2023Point72 Asset Management L.P.905,405$2.67M0.0%N/A2.379%Search for SEC Filing on Google Icon
8/15/2023Stifel Financial Corp24,800$73K0.0%-26.2%0.065%Search for SEC Filing on Google Icon
8/14/2023Potomac Capital Management Inc.74,585$0.22M0.2%-6.8%0.196%Search for SEC Filing on Google Icon
8/14/2023Ergoteles LLC33,600$99K0.0%N/A0.088%Search for SEC Filing on Google Icon
8/14/2023State of Wisconsin Investment Board24,500$72K0.0%-41.9%0.064%Search for SEC Filing on Google Icon
8/14/2023State Street Corp118,481$0.35M0.0%-84.9%0.311%Search for SEC Filing on Google Icon
8/14/2023Prelude Capital Management LLC28,722$85K0.0%-33.1%0.075%Search for SEC Filing on Google Icon
8/11/2023Renaissance Technologies LLC438,800$1.29M0.0%+40.7%1.156%Search for SEC Filing on Google Icon
8/11/2023Nan Fung Group Holdings Ltd11,769$35K0.0%N/A0.031%Search for SEC Filing on Google Icon
8/11/2023BlackRock Inc.669,768$1.98M0.0%-70.5%1.765%Search for SEC Filing on Google Icon
8/11/2023Geode Capital Management LLC293,532$0.87M0.0%-53.6%0.773%Search for SEC Filing on Google Icon
8/11/2023Northern Trust Corp57,418$0.17M0.0%-79.5%0.151%Search for SEC Filing on Google Icon
8/10/2023Osaic Holdings Inc.146,969$0.43M0.0%+7.1%0.387%Search for SEC Filing on Google Icon
8/10/2023Charles Schwab Investment Management Inc.13,857$41K0.0%-85.4%0.037%Search for SEC Filing on Google Icon
8/9/2023Dimensional Fund Advisors LP417,647$1.23M0.0%+19.5%1.100%Search for SEC Filing on Google Icon
8/7/2023Acadian Asset Management LLC244,819$0.72M0.0%-33.3%0.645%Search for SEC Filing on Google Icon
8/3/2023Barclays PLC218,908$0.65M0.0%-7.3%0.575%Search for SEC Filing on Google Icon
8/3/2023Bank of New York Mellon Corp16,278$48K0.0%-85.3%0.043%Search for SEC Filing on Google Icon
7/31/2023Brighton Jones LLC32,200$95K0.0%N/A0.085%Search for SEC Filing on Google Icon
6/1/2023Prelude Capital Management LLC42,957$0.11M0.0%-31.5%0.113%Search for SEC Filing on Google Icon
5/22/2023Ameriprise Financial Inc.11,636$29K0.0%-66.3%0.031%Search for SEC Filing on Google Icon
5/18/2023JPMorgan Chase & Co.27,038$67K0.0%+31.9%0.071%Search for SEC Filing on Google Icon
5/16/2023Geode Capital Management LLC632,348$1.58M0.0%+4.9%1.667%Search for SEC Filing on Google Icon
5/16/2023Baker BROS. Advisors LP2,350,355$5.88M0.0%+25.0%6.194%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Advisers LP494,200$1.24M0.0%+48.8%1.302%Search for SEC Filing on Google Icon
5/15/2023Two Sigma Investments LP421,405$1.05M0.0%+23.8%1.111%Search for SEC Filing on Google Icon
5/15/2023Deutsche Bank AG32,770$82K0.0%+139.0%0.086%Search for SEC Filing on Google Icon
5/12/2023Renaissance Technologies LLC311,865$0.78M0.0%+279.9%0.822%Search for SEC Filing on Google Icon
5/12/2023BlackRock Inc.2,271,458$5.68M0.0%-3.9%5.986%Search for SEC Filing on Google Icon
5/12/2023Bank of America Corp DE473,639$1.18M0.0%+1.0%1.248%Search for SEC Filing on Google Icon
5/12/2023UBS Group AG23,487$59K0.0%-77.2%0.062%Search for SEC Filing on Google Icon
5/12/2023Dimensional Fund Advisors LP349,499$0.87M0.0%+1,200.2%0.921%Search for SEC Filing on Google Icon
5/12/2023Panagora Asset Management Inc.148,803$0.37M0.0%+30.9%0.392%Search for SEC Filing on Google Icon
5/12/2023Charles Schwab Investment Management Inc.95,097$0.24M0.0%+7.1%0.251%Search for SEC Filing on Google Icon
5/11/2023Acadian Asset Management LLC366,915$0.92M0.0%+176.9%0.967%Search for SEC Filing on Google Icon
5/11/2023Cornercap Investment Counsel Inc.75,253$0.19M0.0%N/A0.198%Search for SEC Filing on Google Icon
5/11/2023Bristlecone Advisors LLC85,306$0.21M0.0%-87.8%0.225%Search for SEC Filing on Google Icon
5/10/2023Simplify Asset Management Inc.1,390,148$3.48M0.5%N/A3.664%Search for SEC Filing on Google Icon
5/8/2023Federated Hermes Inc.10,581$26K0.0%+60.6%0.028%Search for SEC Filing on Google Icon
5/8/2023Bailard Inc.33,894$85K0.0%-24.8%0.089%Search for SEC Filing on Google Icon
5/4/2023Barclays PLC236,118$0.59M0.0%+13.5%0.622%Search for SEC Filing on Google Icon
5/2/2023Sargent Investment Group LLC20,272$51K0.0%+34.1%0.053%Search for SEC Filing on Google Icon
4/28/2023SG Americas Securities LLC19,512$49K0.0%+63.6%0.051%Search for SEC Filing on Google Icon
4/17/2023Clarius Group LLC38,000$95K0.0%+15.8%0.100%Search for SEC Filing on Google Icon
4/14/2023BML Capital Management LLC1,864,907$4.66M4.0%+160.9%4.915%Search for SEC Filing on Google Icon
2/16/2023Alliancebernstein L.P.81,900$0.26M0.0%+6.9%0.216%Search for SEC Filing on Google Icon
2/15/2023Public Employees Retirement System of Ohio27,303$87K0.0%-18.5%0.072%Search for SEC Filing on Google Icon
2/15/2023Jane Street Group LLC14,570$46K0.0%-30.7%0.039%Search for SEC Filing on Google Icon
2/15/2023State of Wisconsin Investment Board15,000$48K0.0%N/A0.040%Search for SEC Filing on Google Icon
2/15/2023Schonfeld Strategic Advisors LLC21,000$67K0.0%-25.5%0.056%Search for SEC Filing on Google Icon
2/15/2023Squarepoint Ops LLC17,207$55K0.0%N/A0.045%Search for SEC Filing on Google Icon
2/15/2023Tang Capital Management LLC485,234$1.54M0.2%N/A1.283%Search for SEC Filing on Google Icon
2/15/2023Millennium Management LLC36,426$0.12M0.0%+27.8%0.096%Search for SEC Filing on Google Icon
2/15/2023Morgan Stanley155,881$0.49M0.0%-21.0%0.412%Search for SEC Filing on Google Icon
2/15/2023AQR Capital Management LLC29,952$95K0.0%-86.4%0.079%Search for SEC Filing on Google Icon
2/14/2023RA Capital Management L.P.1,881,300$5.96M0.1%+0.2%4.973%Search for SEC Filing on Google Icon
2/14/2023Bristlecone Advisors LLC696,629$2.21M0.3%-0.6%1.841%Search for SEC Filing on Google Icon
2/14/2023Two Sigma Investments LP340,337$1.08M0.0%-5.6%0.900%Search for SEC Filing on Google Icon
2/14/2023Pura Vida Investments LLC77,700$0.25M0.0%-44.5%0.205%Search for SEC Filing on Google Icon
2/13/2023Deutsche Bank AG13,711$43K0.0%-52.1%0.036%Search for SEC Filing on Google Icon
2/13/2023Forefront Analytics LLC22,350$71K0.0%N/A0.059%Search for SEC Filing on Google Icon
2/13/2023BML Capital Management LLC714,763$2.27M2.2%N/A1.889%Search for SEC Filing on Google Icon
2/13/2023Panagora Asset Management Inc.113,652$0.36M0.0%+78.8%0.300%Search for SEC Filing on Google Icon
2/13/2023Barclays PLC208,089$0.66M0.0%+24.8%0.550%Search for SEC Filing on Google Icon
2/13/2023Renaissance Technologies LLC82,100$0.26M0.0%-65.1%0.217%Search for SEC Filing on Google Icon
2/13/2023Geode Capital Management LLC602,553$1.91M0.0%+1.7%1.593%Search for SEC Filing on Google Icon
2/13/2023GSA Capital Partners LLP270,989$0.86M0.1%+59.9%0.716%Search for SEC Filing on Google Icon
2/10/2023Bank of America Corp DE469,165$1.49M0.0%-4.1%1.240%Search for SEC Filing on Google Icon
2/10/2023Advisor Group Holdings Inc.146,569$0.46M0.0%+7.8%0.387%Search for SEC Filing on Google Icon
2/9/2023Dimensional Fund Advisors LP26,881$85K0.0%+28.6%0.071%Search for SEC Filing on Google Icon
2/8/2023UBS Group AG102,844$0.33M0.0%+57.9%0.272%Search for SEC Filing on Google Icon
2/2/2023Bailard Inc.45,094$0.14M0.0%N/A0.119%Search for SEC Filing on Google Icon
1/25/2023Lindbrook Capital LLC11,407$36K0.0%-32.6%0.030%Search for SEC Filing on Google Icon
1/19/2023Rothschild Investment Corp IL31,100$99K0.0%N/A0.082%Search for SEC Filing on Google Icon
12/8/2022Bank of New York Mellon Corp109,796$0.33M0.0%+16.4%0.290%Search for SEC Filing on Google Icon
11/16/2022Balyasny Asset Management LLC12,518$37K0.0%N/A0.033%Search for SEC Filing on Google Icon
11/16/2022Jane Street Group LLC21,027$63K0.0%-68.7%0.056%Search for SEC Filing on Google Icon
11/15/2022Alliancebernstein L.P.76,600$0.23M0.0%+14.5%0.202%Search for SEC Filing on Google Icon
11/15/2022State Street Corp782,154$2.32M0.0%-14.1%2.068%Search for SEC Filing on Google Icon
11/15/2022Public Employees Retirement System of Ohio33,500$99K0.0%N/A0.089%Search for SEC Filing on Google Icon
11/15/2022Jacobs Levy Equity Management Inc.251,935$0.75M0.0%N/A0.666%Search for SEC Filing on Google Icon
11/15/2022Algert Global LLC35,190$0.11M0.0%N/A0.093%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Advisers LP347,400$1.03M0.0%+229.0%0.918%Search for SEC Filing on Google Icon
11/15/2022Two Sigma Investments LP360,643$1.07M0.0%+29.5%0.953%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Athira Pharma logo
Athira Pharma, Inc., a late clinical-stage biopharmaceutical company, focuses on developing small molecules to restore neuronal health and slow neurodegradation. Its lead product candidate is ATH-1017 Fosgonimeton, a small molecule designed to enhance the activity of hepatocyte growth factor (HGF) and its receptor, MET, for a healthy nervous system that is in LIFT-AD Phase 2/3 and ACT-AD Phase 2 clinical trials for the treatment of Alzheimer's disease, as well as is in Phase 2 clinical trials to treat Parkinson's disease. The company's product pipeline includes ATH-1020, an orally available brain-penetrant small molecule designed to enhance the HGF/MET system that is in Phase 1 clinical trials to treat neuropathic pain and neurodegenerative diseases; and ATH-1105, an orally available, brain-penetrant small molecule positive modulator of HGF/MET which is a preclinical model for the treatment of Amyotrophic Lateral Sclerosis. In addition, it has a license agreement with Washington State University to offer for sale products covered by certain licensed patents, including dihexa, the chemical compound into which fosgonimeton metabolizes following administration; and collaboration and grant agreement with National Institutes of Health Grant to support ACT-AD Phase 2 clinical trial for fosgonimeton. Athira Pharma, Inc. was formerly known as M3 Biotechnology, Inc. and changed its name to Athira Pharma, Inc. in April 2019. The company was incorporated in 2011 and is headquartered in Bothell, Washington.
Read More on Athira Pharma

Today's Range

Now: $1.97
Low: $1.83
High: $1.99

50 Day Range

MA: $1.64
Low: $1.39
High: $1.97

52 Week Range

Now: $1.97
Low: $1.33
High: $4.41

Volume

298,247 shs

Average Volume

266,827 shs

Market Capitalization

$74.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.57

Who are the company insiders with the largest holdings of Athira Pharma?

Athira Pharma's top insider shareholders include:
  1. Perceptive Advisors Llc (Director)
  2. Glenna Mileson (CFO)
  3. Mark James Litton (CEO)
  4. Andrew Gengos (Insider)
  5. Hans Moebius (Insider)
  6. Kelly A Romano (Director)
  7. Mark Worthington (General Counsel)
  8. Rachel Lenington (COO)
  9. James A Johnson (Director)
Learn More about top insider investors at Athira Pharma.

Who are the major institutional investors of Athira Pharma?

Athira Pharma's top institutional investors include:
  1. BML Capital Management LLC — 4.48%
  2. Barclays PLC — 1.15%
  3. Jacobs Levy Equity Management Inc. — 0.79%
  4. GSA Capital Partners LLP — 0.78%
  5. Nan Fung Group Holdings Ltd — 0.47%
  6. Laird Norton Trust Company LLC — 0.47%
Learn More about top institutional investors of Athira Pharma stock.

Which major investors are selling Athira Pharma stock?

During the previous quarter, ATHA stock was sold by these institutional investors:
  1. BML Capital Management LLC
  2. Acadian Asset Management LLC
  3. GSA Capital Partners LLP

Which major investors are buying Athira Pharma stock?

Within the previous quarter, ATHA stock was acquired by institutional investors including:
  1. Barclays PLC
  2. Nan Fung Group Holdings Ltd
  3. Acuitas Investments LLC
  4. Jacobs Levy Equity Management Inc.
  5. UBS Group AG
  6. Clarius Group LLC
  7. Laird Norton Trust Company LLC
  8. Marquette Asset Management LLC
During the last year, these company insiders have bought Athira Pharma stock:
  1. Perceptive Advisors Llc (Director)
  2. Glenna Mileson (CFO)
  3. Mark James Litton (CEO)
  4. Andrew Gengos (Insider)
  5. Hans Moebius (Insider)
  6. Kelly A Romano (Director)
Learn More investors buying Athira Pharma stock.
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Check out this training for the full story!